{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "ec44ff12",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pymupdf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "426b1c59",
   "metadata": {},
   "outputs": [],
   "source": [
    "doc = pymupdf.open(\"corpus/A review of sleep disorders and melatonin.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "d507dbd0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "8"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "doc.page_count"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "44f89bc5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'560\\u2003\\n\\u2003 \\ufeffZ. XIE ET AL.\\npsychiatric conditions, including depression, anxiety \\nand substance abuse. People who show a susceptibility \\nto sleep disturbances have an overactive sympathetic \\nnervous system, hyperarousal and have more intense \\nresponses to stressful events [1]. Melatonin levels \\ndecrease\\xa0with age, thus older adults are more prone to \\nsuffer from inadequate melatonin levels [10]. As one \\nages, the ability to sleep decreases, and consequently \\nthe incidences of sleep disorders gradually increase. \\nThe sleep architecture begins to change during middle \\nage, resulting in a dramatic decrease in non-rapid eye \\nmovement (NREM)-slow wave sleep; in contrast the \\namount of rapid eye movement (REM) sleep diminishes \\nonly slightly. Thus, reduced melatonin secretion may be \\ninvolved in the mechanism of insomnia [11].\\nMelatonin has been approved in Europe for the man-\\nagement of primary insomnia in adults over the age of \\n55. Clinical trials have demonstrated that melatonin is \\neffective for treating insomnia in other cohorts, includ-\\ning children with autism spectrum disorders [12], ado-\\nlescents with depression [5], women with premenstrual \\ndysphoric disorder [13], hypertensive patients taking \\nbeta-blockers [14] and children with attention-deficit/\\nhyperactivity disorder [15].\\nMechanistically, human endogenous melatonin levels \\nstart to increase approximately 2 hours before natural \\nsleep onset and peak approximately 5 hours later [5]. \\nPsychophysiological insomnia (PPI) – insomnia perpet-\\nuated by both psychological and physiological factors \\n– usually presents with a history of taking hours to fall \\nasleep and having extreme difficulty waking up in the \\nmorning for school or work [5]. Melatonin alters spe-\\ncific aspects of the sleep architecture, thereby improving \\nsleep quality [13]. Beta-blockers suppress endogenous \\nnight-time melatonin secretion, which may explain \\nthe reported side effect of insomnia. In these patients, \\nmelatonin supplementation significantly increased total \\nsleep time, improved sleep efficiency and decreased sleep \\nonset latency to Stage 2 [14]. Exogenous melatonin can \\neffectively treat insomnia by mimicking the natural \\nendogenous melatonin, binding to the same receptors \\nand activating the same downstream pathways.\\nMelatonin and melatonin agonists play important \\nroles in the treatment of insomnia by activating MT1 \\nand MT2 melatonin receptors. By studying MT1 and \\nMT2 receptor knockout mice, Comai et al. showed \\nthat MT1 and MT2 receptors play different roles in \\nsleep [16]. Merica et al. demonstrated a connection \\nbetween slow wave sleep and insomnia. They reported \\nlower slow wave activity levels during NERM sleep in \\npatients with insomnia compared to healthy cohorts, \\nas well as increased Stage 1 sleep and less Stage 4 sleep. \\nSelective MT2 receptor agonists increase NREMS \\nduration compared to melatonin and non-selective \\nMT1/MT2 agonists [17]. MT1 receptor knockout mice \\nexhibited a significant increase in NREMS during the \\nactive/dark phase [18], whereas MT2 receptor knockout \\nmice showed decreased NREMS duration [18]. Taken \\ntogether, these knockout studies seem to suggest that \\nMT1 and MT2 receptors modulate NREMS in an oppo-\\nsite manner [16]. By activating MT1 and MT2 receptors, \\nmelatonin and non-selective MT1/MT2 receptor ago-\\nnists have shown to improve sleep quality, increase total \\nsleep time, improve sleep efficiency and decrease sleep \\nonset latency in insomnia patients.\\nEffect of melatonin on reducing the \\ncomplications caused by SBDs\\nSBDs are characterized by abnormalities in respira-\\ntion during sleep. These disorders are subcategorized \\ninto obstructive sleep apnoea (OSA) disorders, central \\nsleep apnea disorders, sleep-related hypoventilation \\ndisorders and sleep-related hypoxemia disorders [9]. \\nIt is well documented that SBDs are a risk factor for \\ncognitive impairment [19], type 2 diabetes [20], early \\nrenal damage [21], heart failure [22], atrial fibrillation \\n[23], coronary disease [24], as well as ischemic stroke \\n[25]. The most common treatments for SBDs are con-\\ntinuous\\xa0positive\\xa0airway pressure\\xa0(CPAP), surgery, oral \\nappliances, postural therapy and weight loss. However, \\nthere are significant disadvantages related to the above \\ntreatments, including postoperative recurrence, dental \\ninjury in the case of oral appliance, poor\\xa0tolerance to \\nCPAP, poor sleep quality secondary to postural therapy, \\nand difficulty with weight loss. Considering these com-\\nplications and disadvantages, new\\xa0therapies\\xa0for SBDs \\nare urgently needed.\\nMelatonin has been shown to ameliorate the compli-\\ncations caused by SBDs in both animal models, as well \\nas human clinical trials. Melatonin prevents the well-\\xad\\nrecognized increase in glucose levels that usually follows \\nexposure to intermittent hypoxia in animal models of \\nsleep apnea [26]. By modulating autophagy through the \\n5′ adenosine monophosphate-activated protein kinase \\npathway, melatonin protects against chronic inter-\\nmittent hypoxia-induced cardiac hypertrophy in rats \\n[27]. Additionally, melatonin inhibits the expression of \\ninflammatory cytokines (Tumor necrosis factor alpha, \\nInterleukin-6, and Cyclooxygenase-2) and fibrotic mark-\\ners (PC1 and TGF-beta). Moreover, melatonin treatment \\nmitigates Ca(2+) overloading, decreased Ca(2+) content \\nand lower expression and activity of Ca(2+), leading to \\ndecreased cardiac contractility. These aforementioned \\nmechanisms contribute to cardiac inflammation, vascu-\\nlar endothelium dysfunction and ultimately secondary \\nhypertension, which are interceded by melatonin.\\nMelatonin prevents the development of cardiovascu-\\nlar diseases secondary to SBDs through several mecha-\\nnisms. Prophylactic melatonin in OSA patients has been \\nshown to protect against chronic intermittent hypox-\\nia-induced myocardial inflammation and fibrosis [28] by \\nactivating MT1 and MT2 receptors downstreams [29]. \\nMelatonin and melatonin-mimicking agents inhibit B2 \\n'"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "conteudo_pagina = doc.get_page_text(2)\n",
    "conteudo_pagina"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "e5566de5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "560 \n",
      "  ﻿Z. XIE ET AL.\n",
      "psychiatric conditions, including depression, anxiety \n",
      "and substance abuse. People who show a susceptibility \n",
      "to sleep disturbances have an overactive sympathetic \n",
      "nervous system, hyperarousal and have more intense \n",
      "responses to stressful events . Melatonin levels \n",
      "decrease with age, thus older adults are more prone to \n",
      "suffer from inadequate melatonin levels . As one \n",
      "ages, the ability to sleep decreases, and consequently \n",
      "the incidences of sleep disorders gradually increase. \n",
      "The sleep architecture begins to change during middle \n",
      "age, resulting in a dramatic decrease in non-rapid eye \n",
      "movement (NREM)-slow wave sleep; in contrast the \n",
      "amount of rapid eye movement (REM) sleep diminishes \n",
      "only slightly. Thus, reduced melatonin secretion may be \n",
      "involved in the mechanism of insomnia .\n",
      "Melatonin has been approved in Europe for the management of primary insomnia in adults over the age of \n",
      "55. Clinical trials have demonstrated that melatonin is \n",
      "effective for treating insomnia in other cohorts, including children with autism spectrum disorders , adolescents with depression , women with premenstrual \n",
      "dysphoric disorder , hypertensive patients taking \n",
      "beta-blockers  and children with attention-deficit/\n",
      "hyperactivity disorder .\n",
      "Mechanistically, human endogenous melatonin levels \n",
      "start to increase approximately 2 hours before natural \n",
      "sleep onset and peak approximately 5 hours later . \n",
      "Psychophysiological insomnia (PPI) – insomnia perpetuated by both psychological and physiological factors \n",
      "– usually presents with a history of taking hours to fall \n",
      "asleep and having extreme difficulty waking up in the \n",
      "morning for school or work . Melatonin alters specific aspects of the sleep architecture, thereby improving \n",
      "sleep quality . Beta-blockers suppress endogenous \n",
      "night-time melatonin secretion, which may explain \n",
      "the reported side effect of insomnia. In these patients, \n",
      "melatonin supplementation significantly increased total \n",
      "sleep time, improved sleep efficiency and decreased sleep \n",
      "onset latency to Stage 2 . Exogenous melatonin can \n",
      "effectively treat insomnia by mimicking the natural \n",
      "endogenous melatonin, binding to the same receptors \n",
      "and activating the same downstream pathways.\n",
      "Melatonin and melatonin agonists play important \n",
      "roles in the treatment of insomnia by activating MT1 \n",
      "and MT2 melatonin receptors. By studying MT1 and \n",
      "MT2 receptor knockout mice, Comai et al. showed \n",
      "that MT1 and MT2 receptors play different roles in \n",
      "sleep . Merica et al. demonstrated a connection \n",
      "between slow wave sleep and insomnia. They reported \n",
      "lower slow wave activity levels during NERM sleep in \n",
      "patients with insomnia compared to healthy cohorts, \n",
      "as well as increased Stage 1 sleep and less Stage 4 sleep. \n",
      "Selective MT2 receptor agonists increase NREMS \n",
      "duration compared to melatonin and non-selective \n",
      "MT1/MT2 agonists . MT1 receptor knockout mice \n",
      "exhibited a significant increase in NREMS during the \n",
      "active/dark phase , whereas MT2 receptor knockout \n",
      "mice showed decreased NREMS duration . Taken \n",
      "together, these knockout studies seem to suggest that \n",
      "MT1 and MT2 receptors modulate NREMS in an opposite manner . By activating MT1 and MT2 receptors, \n",
      "melatonin and non-selective MT1/MT2 receptor agonists have shown to improve sleep quality, increase total \n",
      "sleep time, improve sleep efficiency and decrease sleep \n",
      "onset latency in insomnia patients.\n",
      "Effect of melatonin on reducing the \n",
      "complications caused by SBDs\n",
      "SBDs are characterized by abnormalities in respiration during sleep. These disorders are subcategorized \n",
      "into obstructive sleep apnoea (OSA) disorders, central \n",
      "sleep apnea disorders, sleep-related hypoventilation \n",
      "disorders and sleep-related hypoxemia disorders . \n",
      "It is well documented that SBDs are a risk factor for \n",
      "cognitive impairment , type 2 diabetes , early \n",
      "renal damage , heart failure , atrial fibrillation \n",
      ", coronary disease , as well as ischemic stroke \n",
      ". The most common treatments for SBDs are continuous positive airway pressure (CPAP), surgery, oral \n",
      "appliances, postural therapy and weight loss. However, \n",
      "there are significant disadvantages related to the above \n",
      "treatments, including postoperative recurrence, dental \n",
      "injury in the case of oral appliance, poor tolerance to \n",
      "CPAP, poor sleep quality secondary to postural therapy, \n",
      "and difficulty with weight loss. Considering these complications and disadvantages, new therapies for SBDs \n",
      "are urgently needed.\n",
      "Melatonin has been shown to ameliorate the complications caused by SBDs in both animal models, as well \n",
      "as human clinical trials. Melatonin prevents the well-­\n",
      "recognized increase in glucose levels that usually follows \n",
      "exposure to intermittent hypoxia in animal models of \n",
      "sleep apnea . By modulating autophagy through the \n",
      "5′ adenosine monophosphate-activated protein kinase \n",
      "pathway, melatonin protects against chronic intermittent hypoxia-induced cardiac hypertrophy in rats \n",
      ". Additionally, melatonin inhibits the expression of \n",
      "inflammatory cytokines (Tumor necrosis factor alpha, \n",
      "Interleukin-6, and Cyclooxygenase-2) and fibrotic markers (PC1 and TGF-beta). Moreover, melatonin treatment \n",
      "mitigates Ca(2+) overloading, decreased Ca(2+) content \n",
      "and lower expression and activity of Ca(2+), leading to \n",
      "decreased cardiac contractility. These aforementioned \n",
      "mechanisms contribute to cardiac inflammation, vascular endothelium dysfunction and ultimately secondary \n",
      "hypertension, which are interceded by melatonin.\n",
      "Melatonin prevents the development of cardiovascular diseases secondary to SBDs through several mechanisms. Prophylactic melatonin in OSA patients has been \n",
      "shown to protect against chronic intermittent hypoxia-induced myocardial inflammation and fibrosis  by \n",
      "activating MT1 and MT2 receptors downstreams . \n",
      "Melatonin and melatonin-mimicking agents inhibit B2 \n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(conteudo_pagina)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "2a06a5f9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting en-core-web-lg==3.8.0\n",
      "  Downloading https://github.com/explosion/spacy-models/releases/download/en_core_web_lg-3.8.0/en_core_web_lg-3.8.0-py3-none-any.whl (400.7 MB)\n",
      "     ---------------------------------------- 0.0/400.7 MB ? eta -:--:--\n",
      "     --------------------------------------- 1.8/400.7 MB 11.9 MB/s eta 0:00:34\n",
      "     --------------------------------------- 4.2/400.7 MB 11.5 MB/s eta 0:00:35\n",
      "      -------------------------------------- 6.8/400.7 MB 11.6 MB/s eta 0:00:34\n",
      "      -------------------------------------- 9.2/400.7 MB 11.7 MB/s eta 0:00:34\n",
      "     - ------------------------------------ 11.5/400.7 MB 11.7 MB/s eta 0:00:34\n",
      "     - ------------------------------------ 14.2/400.7 MB 11.8 MB/s eta 0:00:33\n",
      "     - ------------------------------------ 16.5/400.7 MB 11.8 MB/s eta 0:00:33\n",
      "     - ------------------------------------ 18.9/400.7 MB 11.8 MB/s eta 0:00:33\n",
      "     -- ----------------------------------- 21.2/400.7 MB 11.8 MB/s eta 0:00:33\n",
      "     -- ----------------------------------- 23.6/400.7 MB 11.8 MB/s eta 0:00:32\n",
      "     -- ----------------------------------- 26.2/400.7 MB 11.8 MB/s eta 0:00:32\n",
      "     -- ----------------------------------- 28.6/400.7 MB 11.8 MB/s eta 0:00:32\n",
      "     -- ----------------------------------- 30.9/400.7 MB 11.8 MB/s eta 0:00:32\n",
      "     --- ---------------------------------- 33.3/400.7 MB 11.8 MB/s eta 0:00:32\n",
      "     --- ---------------------------------- 35.7/400.7 MB 11.8 MB/s eta 0:00:31\n",
      "     --- ---------------------------------- 38.3/400.7 MB 11.8 MB/s eta 0:00:31\n",
      "     --- ---------------------------------- 40.6/400.7 MB 11.8 MB/s eta 0:00:31\n",
      "     ---- --------------------------------- 43.0/400.7 MB 11.8 MB/s eta 0:00:31\n",
      "     ---- --------------------------------- 45.4/400.7 MB 11.8 MB/s eta 0:00:31\n",
      "     ---- --------------------------------- 48.0/400.7 MB 11.8 MB/s eta 0:00:30\n",
      "     ---- --------------------------------- 50.3/400.7 MB 11.8 MB/s eta 0:00:30\n",
      "     ---- --------------------------------- 52.7/400.7 MB 11.8 MB/s eta 0:00:30\n",
      "     ----- -------------------------------- 55.1/400.7 MB 11.8 MB/s eta 0:00:30\n",
      "     ----- -------------------------------- 57.7/400.7 MB 11.8 MB/s eta 0:00:30\n",
      "     ----- -------------------------------- 60.0/400.7 MB 11.8 MB/s eta 0:00:29\n",
      "     ----- -------------------------------- 62.4/400.7 MB 11.8 MB/s eta 0:00:29\n",
      "     ------ ------------------------------- 64.7/400.7 MB 11.8 MB/s eta 0:00:29\n",
      "     ------ ------------------------------- 67.4/400.7 MB 11.8 MB/s eta 0:00:29\n",
      "     ------ ------------------------------- 69.7/400.7 MB 11.8 MB/s eta 0:00:29\n",
      "     ------ ------------------------------- 70.5/400.7 MB 11.8 MB/s eta 0:00:28\n",
      "     ------ ------------------------------- 70.5/400.7 MB 11.8 MB/s eta 0:00:28\n",
      "     ------ ------------------------------- 70.5/400.7 MB 11.8 MB/s eta 0:00:28\n",
      "     ------ ------------------------------- 70.5/400.7 MB 11.8 MB/s eta 0:00:28\n",
      "     ------ ------------------------------- 71.3/400.7 MB 10.3 MB/s eta 0:00:32\n",
      "     ------- ------------------------------ 73.9/400.7 MB 10.4 MB/s eta 0:00:32\n",
      "     ------- ------------------------------ 76.3/400.7 MB 10.4 MB/s eta 0:00:32\n",
      "     ------- ------------------------------ 78.6/400.7 MB 10.4 MB/s eta 0:00:31\n",
      "     ------- ------------------------------ 81.0/400.7 MB 10.5 MB/s eta 0:00:31\n",
      "     ------- ------------------------------ 83.6/400.7 MB 10.5 MB/s eta 0:00:31\n",
      "     -------- ----------------------------- 86.0/400.7 MB 10.5 MB/s eta 0:00:30\n",
      "     -------- ----------------------------- 88.3/400.7 MB 10.6 MB/s eta 0:00:30\n",
      "     -------- ----------------------------- 90.7/400.7 MB 10.6 MB/s eta 0:00:30\n",
      "     -------- ----------------------------- 93.3/400.7 MB 10.6 MB/s eta 0:00:29\n",
      "     --------- ---------------------------- 95.7/400.7 MB 10.7 MB/s eta 0:00:29\n",
      "     --------- ---------------------------- 98.0/400.7 MB 10.7 MB/s eta 0:00:29\n",
      "     --------- --------------------------- 100.4/400.7 MB 10.7 MB/s eta 0:00:29\n",
      "     --------- --------------------------- 102.5/400.7 MB 10.7 MB/s eta 0:00:28\n",
      "     --------- --------------------------- 104.9/400.7 MB 10.7 MB/s eta 0:00:28\n",
      "     --------- --------------------------- 107.0/400.7 MB 10.7 MB/s eta 0:00:28\n",
      "     ---------- -------------------------- 108.8/400.7 MB 10.7 MB/s eta 0:00:28\n",
      "     ---------- -------------------------- 110.9/400.7 MB 10.7 MB/s eta 0:00:28\n",
      "     ---------- -------------------------- 113.2/400.7 MB 10.7 MB/s eta 0:00:27\n",
      "     ---------- -------------------------- 115.6/400.7 MB 10.7 MB/s eta 0:00:27\n",
      "     ---------- -------------------------- 118.0/400.7 MB 10.7 MB/s eta 0:00:27\n",
      "     ----------- ------------------------- 120.6/400.7 MB 10.7 MB/s eta 0:00:27\n",
      "     ----------- ------------------------- 122.9/400.7 MB 10.8 MB/s eta 0:00:26\n",
      "     ----------- ------------------------- 125.3/400.7 MB 10.8 MB/s eta 0:00:26\n",
      "     ----------- ------------------------- 127.7/400.7 MB 10.8 MB/s eta 0:00:26\n",
      "     ------------ ------------------------ 130.0/400.7 MB 10.8 MB/s eta 0:00:26\n",
      "     ------------ ------------------------ 132.6/400.7 MB 10.8 MB/s eta 0:00:25\n",
      "     ------------ ------------------------ 135.0/400.7 MB 10.8 MB/s eta 0:00:25\n",
      "     ------------ ------------------------ 136.3/400.7 MB 10.8 MB/s eta 0:00:25\n",
      "     ------------ ------------------------ 137.6/400.7 MB 10.7 MB/s eta 0:00:25\n",
      "     ------------ ------------------------ 139.2/400.7 MB 10.7 MB/s eta 0:00:25\n",
      "     ------------ ------------------------ 140.8/400.7 MB 10.6 MB/s eta 0:00:25\n",
      "     ------------- ----------------------- 142.6/400.7 MB 10.6 MB/s eta 0:00:25\n",
      "     ------------- ----------------------- 144.7/400.7 MB 10.6 MB/s eta 0:00:25\n",
      "     ------------- ----------------------- 146.5/400.7 MB 10.6 MB/s eta 0:00:25\n",
      "     ------------- ----------------------- 148.9/400.7 MB 10.6 MB/s eta 0:00:24\n",
      "     ------------- ----------------------- 151.3/400.7 MB 10.6 MB/s eta 0:00:24\n",
      "     -------------- ---------------------- 153.6/400.7 MB 10.6 MB/s eta 0:00:24\n",
      "     -------------- ---------------------- 156.0/400.7 MB 10.6 MB/s eta 0:00:24\n",
      "     -------------- ---------------------- 158.3/400.7 MB 10.6 MB/s eta 0:00:23\n",
      "     -------------- ---------------------- 160.7/400.7 MB 10.6 MB/s eta 0:00:23\n",
      "     --------------- --------------------- 163.3/400.7 MB 10.7 MB/s eta 0:00:23\n",
      "     --------------- --------------------- 165.7/400.7 MB 10.7 MB/s eta 0:00:23\n",
      "     --------------- --------------------- 168.0/400.7 MB 10.7 MB/s eta 0:00:22\n",
      "     --------------- --------------------- 170.1/400.7 MB 10.7 MB/s eta 0:00:22\n",
      "     --------------- --------------------- 171.2/400.7 MB 10.6 MB/s eta 0:00:22\n",
      "     --------------- --------------------- 173.0/400.7 MB 10.6 MB/s eta 0:00:22\n",
      "     ---------------- -------------------- 174.3/400.7 MB 10.6 MB/s eta 0:00:22\n",
      "     ---------------- -------------------- 175.9/400.7 MB 10.5 MB/s eta 0:00:22\n",
      "     ---------------- -------------------- 177.5/400.7 MB 10.5 MB/s eta 0:00:22\n",
      "     ---------------- -------------------- 179.3/400.7 MB 10.5 MB/s eta 0:00:22\n",
      "     ---------------- -------------------- 181.1/400.7 MB 10.4 MB/s eta 0:00:22\n",
      "     ---------------- -------------------- 183.5/400.7 MB 10.4 MB/s eta 0:00:21\n",
      "     ----------------- ------------------- 185.6/400.7 MB 10.4 MB/s eta 0:00:21\n",
      "     ----------------- ------------------- 188.0/400.7 MB 10.5 MB/s eta 0:00:21\n",
      "     ----------------- ------------------- 190.6/400.7 MB 10.5 MB/s eta 0:00:21\n",
      "     ----------------- ------------------- 192.9/400.7 MB 10.5 MB/s eta 0:00:20\n",
      "     ------------------ ------------------ 195.3/400.7 MB 10.5 MB/s eta 0:00:20\n",
      "     ------------------ ------------------ 197.7/400.7 MB 10.5 MB/s eta 0:00:20\n",
      "     ------------------ ------------------ 200.3/400.7 MB 10.5 MB/s eta 0:00:20\n",
      "     ------------------ ------------------ 202.6/400.7 MB 10.5 MB/s eta 0:00:19\n",
      "     ------------------ ------------------ 205.0/400.7 MB 10.6 MB/s eta 0:00:19\n",
      "     ------------------- ----------------- 207.4/400.7 MB 10.6 MB/s eta 0:00:19\n",
      "     ------------------- ----------------- 209.7/400.7 MB 10.6 MB/s eta 0:00:19\n",
      "     ------------------- ----------------- 212.1/400.7 MB 10.6 MB/s eta 0:00:18\n",
      "     ------------------- ----------------- 214.4/400.7 MB 10.6 MB/s eta 0:00:18\n",
      "     -------------------- ---------------- 217.1/400.7 MB 10.6 MB/s eta 0:00:18\n",
      "     -------------------- ---------------- 219.2/400.7 MB 10.6 MB/s eta 0:00:18\n",
      "     -------------------- ---------------- 221.5/400.7 MB 10.6 MB/s eta 0:00:17\n",
      "     -------------------- ---------------- 223.9/400.7 MB 10.6 MB/s eta 0:00:17\n",
      "     -------------------- ---------------- 225.7/400.7 MB 10.6 MB/s eta 0:00:17\n",
      "     --------------------- --------------- 227.8/400.7 MB 10.6 MB/s eta 0:00:17\n",
      "     --------------------- --------------- 230.2/400.7 MB 10.6 MB/s eta 0:00:17\n",
      "     --------------------- --------------- 232.5/400.7 MB 10.6 MB/s eta 0:00:16\n",
      "     --------------------- --------------- 235.1/400.7 MB 10.6 MB/s eta 0:00:16\n",
      "     --------------------- --------------- 237.5/400.7 MB 10.7 MB/s eta 0:00:16\n",
      "     ---------------------- -------------- 239.9/400.7 MB 10.7 MB/s eta 0:00:16\n",
      "     ---------------------- -------------- 242.2/400.7 MB 10.7 MB/s eta 0:00:15\n",
      "     ---------------------- -------------- 244.6/400.7 MB 10.7 MB/s eta 0:00:15\n",
      "     ---------------------- -------------- 247.2/400.7 MB 10.7 MB/s eta 0:00:15\n",
      "     ----------------------- ------------- 249.6/400.7 MB 10.7 MB/s eta 0:00:15\n",
      "     ----------------------- ------------- 251.9/400.7 MB 10.7 MB/s eta 0:00:14\n",
      "     ----------------------- ------------- 254.3/400.7 MB 10.7 MB/s eta 0:00:14\n",
      "     ----------------------- ------------- 256.6/400.7 MB 10.7 MB/s eta 0:00:14\n",
      "     ----------------------- ------------- 259.3/400.7 MB 10.7 MB/s eta 0:00:14\n",
      "     ------------------------ ------------ 261.6/400.7 MB 10.8 MB/s eta 0:00:13\n",
      "     ------------------------ ------------ 264.0/400.7 MB 10.8 MB/s eta 0:00:13\n",
      "     ------------------------ ------------ 266.3/400.7 MB 10.8 MB/s eta 0:00:13\n",
      "     ------------------------ ------------ 269.0/400.7 MB 10.8 MB/s eta 0:00:13\n",
      "     ------------------------- ----------- 271.3/400.7 MB 10.8 MB/s eta 0:00:13\n",
      "     ------------------------- ----------- 273.7/400.7 MB 10.8 MB/s eta 0:00:12\n",
      "     ------------------------- ----------- 275.5/400.7 MB 10.8 MB/s eta 0:00:12\n",
      "     ------------------------- ----------- 277.3/400.7 MB 10.7 MB/s eta 0:00:12\n",
      "     ------------------------- ----------- 278.4/400.7 MB 10.7 MB/s eta 0:00:12\n",
      "     ------------------------- ----------- 279.4/400.7 MB 10.6 MB/s eta 0:00:12\n",
      "     ------------------------- ----------- 280.2/400.7 MB 10.6 MB/s eta 0:00:12\n",
      "     ------------------------- ----------- 280.2/400.7 MB 10.6 MB/s eta 0:00:12\n",
      "     ------------------------- ----------- 280.2/400.7 MB 10.6 MB/s eta 0:00:12\n",
      "     ------------------------- ----------- 280.8/400.7 MB 10.4 MB/s eta 0:00:12\n",
      "     ------------------------- ----------- 281.5/400.7 MB 10.3 MB/s eta 0:00:12\n",
      "     -------------------------- ---------- 282.6/400.7 MB 10.2 MB/s eta 0:00:12\n",
      "     -------------------------- ---------- 283.6/400.7 MB 10.2 MB/s eta 0:00:12\n",
      "     -------------------------- ---------- 285.0/400.7 MB 10.1 MB/s eta 0:00:12\n",
      "     -------------------------- ---------- 286.5/400.7 MB 10.1 MB/s eta 0:00:12\n",
      "     -------------------------- ---------- 288.1/400.7 MB 10.1 MB/s eta 0:00:12\n",
      "     -------------------------- ---------- 289.7/400.7 MB 10.1 MB/s eta 0:00:12\n",
      "     -------------------------- ---------- 291.8/400.7 MB 10.0 MB/s eta 0:00:11\n",
      "     --------------------------- --------- 293.6/400.7 MB 10.0 MB/s eta 0:00:11\n",
      "     --------------------------- --------- 296.0/400.7 MB 10.0 MB/s eta 0:00:11\n",
      "     --------------------------- --------- 297.5/400.7 MB 10.0 MB/s eta 0:00:11\n",
      "     --------------------------- --------- 299.4/400.7 MB 10.0 MB/s eta 0:00:11\n",
      "     --------------------------- --------- 301.2/400.7 MB 10.0 MB/s eta 0:00:10\n",
      "     ---------------------------- --------- 303.3/400.7 MB 9.9 MB/s eta 0:00:10\n",
      "     ---------------------------- --------- 305.4/400.7 MB 9.9 MB/s eta 0:00:10\n",
      "     ----------------------------- -------- 307.0/400.7 MB 9.9 MB/s eta 0:00:10\n",
      "     ----------------------------- -------- 308.3/400.7 MB 9.9 MB/s eta 0:00:10\n",
      "     ----------------------------- -------- 309.6/400.7 MB 9.8 MB/s eta 0:00:10\n",
      "     ----------------------------- -------- 311.2/400.7 MB 9.8 MB/s eta 0:00:10\n",
      "     ----------------------------- -------- 313.0/400.7 MB 9.8 MB/s eta 0:00:09\n",
      "     ----------------------------- -------- 314.8/400.7 MB 9.8 MB/s eta 0:00:09\n",
      "     ------------------------------ ------- 316.9/400.7 MB 9.8 MB/s eta 0:00:09\n",
      "     ------------------------------ ------- 319.0/400.7 MB 9.8 MB/s eta 0:00:09\n",
      "     ------------------------------ ------- 321.4/400.7 MB 9.7 MB/s eta 0:00:09\n",
      "     ------------------------------ ------- 323.7/400.7 MB 9.7 MB/s eta 0:00:08\n",
      "     ------------------------------ ------- 325.8/400.7 MB 9.7 MB/s eta 0:00:08\n",
      "     ------------------------------- ------ 327.9/400.7 MB 9.7 MB/s eta 0:00:08\n",
      "     ------------------------------- ------ 329.5/400.7 MB 9.7 MB/s eta 0:00:08\n",
      "     ------------------------------- ------ 331.4/400.7 MB 9.7 MB/s eta 0:00:08\n",
      "     ------------------------------- ------ 332.1/400.7 MB 9.6 MB/s eta 0:00:08\n",
      "     ------------------------------- ------ 332.9/400.7 MB 9.9 MB/s eta 0:00:07\n",
      "     ------------------------------- ------ 333.7/400.7 MB 9.8 MB/s eta 0:00:07\n",
      "     ------------------------------- ------ 334.5/400.7 MB 9.8 MB/s eta 0:00:07\n",
      "     ------------------------------- ------ 335.8/400.7 MB 9.8 MB/s eta 0:00:07\n",
      "     -------------------------------- ----- 337.6/400.7 MB 9.7 MB/s eta 0:00:07\n",
      "     -------------------------------- ----- 339.2/400.7 MB 9.7 MB/s eta 0:00:07\n",
      "     -------------------------------- ----- 341.3/400.7 MB 9.7 MB/s eta 0:00:07\n",
      "     -------------------------------- ----- 342.9/400.7 MB 9.7 MB/s eta 0:00:06\n",
      "     -------------------------------- ----- 344.2/400.7 MB 9.7 MB/s eta 0:00:06\n",
      "     -------------------------------- ----- 345.5/400.7 MB 9.6 MB/s eta 0:00:06\n",
      "     -------------------------------- ----- 346.8/400.7 MB 9.6 MB/s eta 0:00:06\n",
      "     --------------------------------- ---- 348.1/400.7 MB 9.6 MB/s eta 0:00:06\n",
      "     --------------------------------- ---- 349.2/400.7 MB 9.5 MB/s eta 0:00:06\n",
      "     --------------------------------- ---- 350.5/400.7 MB 9.5 MB/s eta 0:00:06\n",
      "     --------------------------------- ---- 352.1/400.7 MB 9.5 MB/s eta 0:00:06\n",
      "     --------------------------------- ---- 352.6/400.7 MB 9.4 MB/s eta 0:00:06\n",
      "     --------------------------------- ---- 353.9/400.7 MB 9.4 MB/s eta 0:00:05\n",
      "     --------------------------------- ---- 354.9/400.7 MB 9.3 MB/s eta 0:00:05\n",
      "     --------------------------------- ---- 356.5/400.7 MB 9.3 MB/s eta 0:00:05\n",
      "     --------------------------------- ---- 358.1/400.7 MB 9.3 MB/s eta 0:00:05\n",
      "     ---------------------------------- --- 359.9/400.7 MB 9.3 MB/s eta 0:00:05\n",
      "     ---------------------------------- --- 362.0/400.7 MB 9.3 MB/s eta 0:00:05\n",
      "     ---------------------------------- --- 364.1/400.7 MB 9.3 MB/s eta 0:00:04\n",
      "     ---------------------------------- --- 366.2/400.7 MB 9.3 MB/s eta 0:00:04\n",
      "     ---------------------------------- --- 367.8/400.7 MB 9.3 MB/s eta 0:00:04\n",
      "     ----------------------------------- -- 369.9/400.7 MB 9.2 MB/s eta 0:00:04\n",
      "     ----------------------------------- -- 372.0/400.7 MB 9.2 MB/s eta 0:00:04\n",
      "     ----------------------------------- -- 373.3/400.7 MB 9.2 MB/s eta 0:00:03\n",
      "     ----------------------------------- -- 374.6/400.7 MB 9.2 MB/s eta 0:00:03\n",
      "     ----------------------------------- -- 375.7/400.7 MB 9.1 MB/s eta 0:00:03\n",
      "     ----------------------------------- -- 376.7/400.7 MB 9.1 MB/s eta 0:00:03\n",
      "     ----------------------------------- -- 377.2/400.7 MB 9.1 MB/s eta 0:00:03\n",
      "     ----------------------------------- -- 377.7/400.7 MB 9.0 MB/s eta 0:00:03\n",
      "     ----------------------------------- -- 378.5/400.7 MB 9.0 MB/s eta 0:00:03\n",
      "     ----------------------------------- -- 379.1/400.7 MB 8.9 MB/s eta 0:00:03\n",
      "     ------------------------------------ - 379.6/400.7 MB 8.9 MB/s eta 0:00:03\n",
      "     ------------------------------------ - 380.1/400.7 MB 8.8 MB/s eta 0:00:03\n",
      "     ------------------------------------ - 380.6/400.7 MB 8.8 MB/s eta 0:00:03\n",
      "     ------------------------------------ - 381.2/400.7 MB 8.8 MB/s eta 0:00:03\n",
      "     ------------------------------------ - 381.4/400.7 MB 8.7 MB/s eta 0:00:03\n",
      "     ------------------------------------ - 381.9/400.7 MB 8.6 MB/s eta 0:00:03\n",
      "     ------------------------------------ - 382.7/400.7 MB 8.5 MB/s eta 0:00:03\n",
      "     ------------------------------------ - 383.5/400.7 MB 8.5 MB/s eta 0:00:03\n",
      "     ------------------------------------ - 384.3/400.7 MB 8.4 MB/s eta 0:00:02\n",
      "     ------------------------------------ - 385.4/400.7 MB 8.4 MB/s eta 0:00:02\n",
      "     ------------------------------------ - 386.7/400.7 MB 8.4 MB/s eta 0:00:02\n",
      "     ------------------------------------ - 388.2/400.7 MB 8.4 MB/s eta 0:00:02\n",
      "     ------------------------------------ - 389.5/400.7 MB 8.4 MB/s eta 0:00:02\n",
      "     -------------------------------------  391.4/400.7 MB 8.4 MB/s eta 0:00:02\n",
      "     -------------------------------------  393.2/400.7 MB 8.4 MB/s eta 0:00:01\n",
      "     -------------------------------------  395.3/400.7 MB 8.4 MB/s eta 0:00:01\n",
      "     -------------------------------------  397.1/400.7 MB 8.4 MB/s eta 0:00:01\n",
      "     -------------------------------------  399.5/400.7 MB 8.4 MB/s eta 0:00:01\n",
      "     -------------------------------------  400.6/400.7 MB 8.4 MB/s eta 0:00:01\n",
      "     -------------------------------------  400.6/400.7 MB 8.4 MB/s eta 0:00:01\n",
      "     -------------------------------------  400.6/400.7 MB 8.4 MB/s eta 0:00:01\n",
      "     ---------------------------------------- 400.7/400.7 MB 8.1 MB/s  0:00:44\n",
      "\u001b[38;5;2m✔ Download and installation successful\u001b[0m\n",
      "You can now load the package via spacy.load('en_core_web_lg')\n"
     ]
    }
   ],
   "source": [
    "!python -m spacy download en_core_web_lg"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "875f114e",
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "60a095e7",
   "metadata": {},
   "outputs": [],
   "source": [
    "nlp = spacy.load(\"en_core_web_lg\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "aa73601c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'spacy.lang.en.English'>\n"
     ]
    }
   ],
   "source": [
    "print(type(nlp))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "8bac66e6",
   "metadata": {},
   "outputs": [],
   "source": [
    "nlp.max_length = 3000000"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ec319daa",
   "metadata": {},
   "outputs": [],
   "source": [
    "doc = nlp(conteudo_pagina)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "fcac8f53",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "-560\n",
      "- \n",
      "  \n",
      "-﻿Z.\n",
      "-XIE\n",
      "-ET\n",
      "-AL\n",
      "-.\n",
      "-\n",
      "\n",
      "-psychiatric\n",
      "-conditions\n",
      "-,\n",
      "-including\n",
      "-depression\n",
      "-,\n",
      "-anxiety\n",
      "-\n",
      "\n",
      "-and\n",
      "-substance\n",
      "-abuse\n",
      "-.\n",
      "-People\n",
      "-who\n",
      "-show\n",
      "-a\n",
      "-susceptibility\n",
      "-\n",
      "\n",
      "-to\n",
      "-sleep\n",
      "-disturbances\n",
      "-have\n",
      "-an\n",
      "-overactive\n",
      "-sympathetic\n",
      "-\n",
      "\n",
      "-nervous\n",
      "-system\n",
      "-,\n",
      "-hyperarousal\n",
      "-and\n",
      "-have\n",
      "-more\n",
      "-intense\n",
      "-\n",
      "\n",
      "-responses\n",
      "-to\n",
      "-stressful\n",
      "-events\n",
      "-[\n",
      "-1\n",
      "-]\n",
      "-.\n",
      "-Melatonin\n",
      "-levels\n",
      "-\n",
      "\n",
      "-decrease\n",
      "- \n",
      "-with\n",
      "-age\n",
      "-,\n",
      "-thus\n",
      "-older\n",
      "-adults\n",
      "-are\n",
      "-more\n",
      "-prone\n",
      "-to\n",
      "-\n",
      "\n",
      "-suffer\n",
      "-from\n",
      "-inadequate\n",
      "-melatonin\n",
      "-levels\n",
      "-[\n",
      "-10\n",
      "-]\n",
      "-.\n",
      "-As\n",
      "-one\n",
      "-\n",
      "\n",
      "-ages\n",
      "-,\n",
      "-the\n",
      "-ability\n",
      "-to\n",
      "-sleep\n",
      "-decreases\n",
      "-,\n",
      "-and\n",
      "-consequently\n",
      "-\n",
      "\n",
      "-the\n",
      "-incidences\n",
      "-of\n",
      "-sleep\n",
      "-disorders\n",
      "-gradually\n",
      "-increase\n",
      "-.\n",
      "-\n",
      "\n",
      "-The\n",
      "-sleep\n",
      "-architecture\n",
      "-begins\n",
      "-to\n",
      "-change\n",
      "-during\n",
      "-middle\n",
      "-\n",
      "\n",
      "-age\n",
      "-,\n",
      "-resulting\n",
      "-in\n",
      "-a\n",
      "-dramatic\n",
      "-decrease\n",
      "-in\n",
      "-non\n",
      "--\n",
      "-rapid\n",
      "-eye\n",
      "-\n",
      "\n",
      "-movement\n",
      "-(\n",
      "-NREM)-slow\n",
      "-wave\n",
      "-sleep\n",
      "-;\n",
      "-in\n",
      "-contrast\n",
      "-the\n",
      "-\n",
      "\n",
      "-amount\n",
      "-of\n",
      "-rapid\n",
      "-eye\n",
      "-movement\n",
      "-(\n",
      "-REM\n",
      "-)\n",
      "-sleep\n",
      "-diminishes\n",
      "-\n",
      "\n",
      "-only\n",
      "-slightly\n",
      "-.\n",
      "-Thus\n",
      "-,\n",
      "-reduced\n",
      "-melatonin\n",
      "-secretion\n",
      "-may\n",
      "-be\n",
      "-\n",
      "\n",
      "-involved\n",
      "-in\n",
      "-the\n",
      "-mechanism\n",
      "-of\n",
      "-insomnia\n",
      "-[\n",
      "-11\n",
      "-]\n",
      "-.\n",
      "-\n",
      "\n",
      "-Melatonin\n",
      "-has\n",
      "-been\n",
      "-approved\n",
      "-in\n",
      "-Europe\n",
      "-for\n",
      "-the\n",
      "-man-\n",
      "-\n",
      "\n",
      "-agement\n",
      "-of\n",
      "-primary\n",
      "-insomnia\n",
      "-in\n",
      "-adults\n",
      "-over\n",
      "-the\n",
      "-age\n",
      "-of\n",
      "-\n",
      "\n",
      "-55\n",
      "-.\n",
      "-Clinical\n",
      "-trials\n",
      "-have\n",
      "-demonstrated\n",
      "-that\n",
      "-melatonin\n",
      "-is\n",
      "-\n",
      "\n",
      "-effective\n",
      "-for\n",
      "-treating\n",
      "-insomnia\n",
      "-in\n",
      "-other\n",
      "-cohorts\n",
      "-,\n",
      "-includ-\n",
      "-\n",
      "\n",
      "-ing\n",
      "-children\n",
      "-with\n",
      "-autism\n",
      "-spectrum\n",
      "-disorders\n",
      "-[\n",
      "-12\n",
      "-]\n",
      "-,\n",
      "-ado-\n",
      "-\n",
      "\n",
      "-lescents\n",
      "-with\n",
      "-depression\n",
      "-[\n",
      "-5\n",
      "-]\n",
      "-,\n",
      "-women\n",
      "-with\n",
      "-premenstrual\n",
      "-\n",
      "\n",
      "-dysphoric\n",
      "-disorder\n",
      "-[\n",
      "-13\n",
      "-]\n",
      "-,\n",
      "-hypertensive\n",
      "-patients\n",
      "-taking\n",
      "-\n",
      "\n",
      "-beta\n",
      "--\n",
      "-blockers\n",
      "-[\n",
      "-14\n",
      "-]\n",
      "-and\n",
      "-children\n",
      "-with\n",
      "-attention\n",
      "--\n",
      "-deficit/\n",
      "-\n",
      "\n",
      "-hyperactivity\n",
      "-disorder\n",
      "-[\n",
      "-15\n",
      "-]\n",
      "-.\n",
      "-\n",
      "\n",
      "-Mechanistically\n",
      "-,\n",
      "-human\n",
      "-endogenous\n",
      "-melatonin\n",
      "-levels\n",
      "-\n",
      "\n",
      "-start\n",
      "-to\n",
      "-increase\n",
      "-approximately\n",
      "-2\n",
      "-hours\n",
      "-before\n",
      "-natural\n",
      "-\n",
      "\n",
      "-sleep\n",
      "-onset\n",
      "-and\n",
      "-peak\n",
      "-approximately\n",
      "-5\n",
      "-hours\n",
      "-later\n",
      "-[\n",
      "-5\n",
      "-]\n",
      "-.\n",
      "-\n",
      "\n",
      "-Psychophysiological\n",
      "-insomnia\n",
      "-(\n",
      "-PPI\n",
      "-)\n",
      "-–\n",
      "-insomnia\n",
      "-perpet-\n",
      "-\n",
      "\n",
      "-uated\n",
      "-by\n",
      "-both\n",
      "-psychological\n",
      "-and\n",
      "-physiological\n",
      "-factors\n",
      "-\n",
      "\n",
      "-–\n",
      "-usually\n",
      "-presents\n",
      "-with\n",
      "-a\n",
      "-history\n",
      "-of\n",
      "-taking\n",
      "-hours\n",
      "-to\n",
      "-fall\n",
      "-\n",
      "\n",
      "-asleep\n",
      "-and\n",
      "-having\n",
      "-extreme\n",
      "-difficulty\n",
      "-waking\n",
      "-up\n",
      "-in\n",
      "-the\n",
      "-\n",
      "\n",
      "-morning\n",
      "-for\n",
      "-school\n",
      "-or\n",
      "-work\n",
      "-[\n",
      "-5\n",
      "-]\n",
      "-.\n",
      "-Melatonin\n",
      "-alters\n",
      "-spe-\n",
      "-\n",
      "\n",
      "-cific\n",
      "-aspects\n",
      "-of\n",
      "-the\n",
      "-sleep\n",
      "-architecture\n",
      "-,\n",
      "-thereby\n",
      "-improving\n",
      "-\n",
      "\n",
      "-sleep\n",
      "-quality\n",
      "-[\n",
      "-13\n",
      "-]\n",
      "-.\n",
      "-Beta\n",
      "--\n",
      "-blockers\n",
      "-suppress\n",
      "-endogenous\n",
      "-\n",
      "\n",
      "-night\n",
      "--\n",
      "-time\n",
      "-melatonin\n",
      "-secretion\n",
      "-,\n",
      "-which\n",
      "-may\n",
      "-explain\n",
      "-\n",
      "\n",
      "-the\n",
      "-reported\n",
      "-side\n",
      "-effect\n",
      "-of\n",
      "-insomnia\n",
      "-.\n",
      "-In\n",
      "-these\n",
      "-patients\n",
      "-,\n",
      "-\n",
      "\n",
      "-melatonin\n",
      "-supplementation\n",
      "-significantly\n",
      "-increased\n",
      "-total\n",
      "-\n",
      "\n",
      "-sleep\n",
      "-time\n",
      "-,\n",
      "-improved\n",
      "-sleep\n",
      "-efficiency\n",
      "-and\n",
      "-decreased\n",
      "-sleep\n",
      "-\n",
      "\n",
      "-onset\n",
      "-latency\n",
      "-to\n",
      "-Stage\n",
      "-2\n",
      "-[\n",
      "-14\n",
      "-]\n",
      "-.\n",
      "-Exogenous\n",
      "-melatonin\n",
      "-can\n",
      "-\n",
      "\n",
      "-effectively\n",
      "-treat\n",
      "-insomnia\n",
      "-by\n",
      "-mimicking\n",
      "-the\n",
      "-natural\n",
      "-\n",
      "\n",
      "-endogenous\n",
      "-melatonin\n",
      "-,\n",
      "-binding\n",
      "-to\n",
      "-the\n",
      "-same\n",
      "-receptors\n",
      "-\n",
      "\n",
      "-and\n",
      "-activating\n",
      "-the\n",
      "-same\n",
      "-downstream\n",
      "-pathways\n",
      "-.\n",
      "-\n",
      "\n",
      "-Melatonin\n",
      "-and\n",
      "-melatonin\n",
      "-agonists\n",
      "-play\n",
      "-important\n",
      "-\n",
      "\n",
      "-roles\n",
      "-in\n",
      "-the\n",
      "-treatment\n",
      "-of\n",
      "-insomnia\n",
      "-by\n",
      "-activating\n",
      "-MT1\n",
      "-\n",
      "\n",
      "-and\n",
      "-MT2\n",
      "-melatonin\n",
      "-receptors\n",
      "-.\n",
      "-By\n",
      "-studying\n",
      "-MT1\n",
      "-and\n",
      "-\n",
      "\n",
      "-MT2\n",
      "-receptor\n",
      "-knockout\n",
      "-mice\n",
      "-,\n",
      "-Comai\n",
      "-et\n",
      "-al\n",
      "-.\n",
      "-showed\n",
      "-\n",
      "\n",
      "-that\n",
      "-MT1\n",
      "-and\n",
      "-MT2\n",
      "-receptors\n",
      "-play\n",
      "-different\n",
      "-roles\n",
      "-in\n",
      "-\n",
      "\n",
      "-sleep\n",
      "-[\n",
      "-16\n",
      "-]\n",
      "-.\n",
      "-Merica\n",
      "-et\n",
      "-al\n",
      "-.\n",
      "-demonstrated\n",
      "-a\n",
      "-connection\n",
      "-\n",
      "\n",
      "-between\n",
      "-slow\n",
      "-wave\n",
      "-sleep\n",
      "-and\n",
      "-insomnia\n",
      "-.\n",
      "-They\n",
      "-reported\n",
      "-\n",
      "\n",
      "-lower\n",
      "-slow\n",
      "-wave\n",
      "-activity\n",
      "-levels\n",
      "-during\n",
      "-NERM\n",
      "-sleep\n",
      "-in\n",
      "-\n",
      "\n",
      "-patients\n",
      "-with\n",
      "-insomnia\n",
      "-compared\n",
      "-to\n",
      "-healthy\n",
      "-cohorts\n",
      "-,\n",
      "-\n",
      "\n",
      "-as\n",
      "-well\n",
      "-as\n",
      "-increased\n",
      "-Stage\n",
      "-1\n",
      "-sleep\n",
      "-and\n",
      "-less\n",
      "-Stage\n",
      "-4\n",
      "-sleep\n",
      "-.\n",
      "-\n",
      "\n",
      "-Selective\n",
      "-MT2\n",
      "-receptor\n",
      "-agonists\n",
      "-increase\n",
      "-NREMS\n",
      "-\n",
      "\n",
      "-duration\n",
      "-compared\n",
      "-to\n",
      "-melatonin\n",
      "-and\n",
      "-non\n",
      "--\n",
      "-selective\n",
      "-\n",
      "\n",
      "-MT1\n",
      "-/\n",
      "-MT2\n",
      "-agonists\n",
      "-[\n",
      "-17\n",
      "-]\n",
      "-.\n",
      "-MT1\n",
      "-receptor\n",
      "-knockout\n",
      "-mice\n",
      "-\n",
      "\n",
      "-exhibited\n",
      "-a\n",
      "-significant\n",
      "-increase\n",
      "-in\n",
      "-NREMS\n",
      "-during\n",
      "-the\n",
      "-\n",
      "\n",
      "-active\n",
      "-/\n",
      "-dark\n",
      "-phase\n",
      "-[\n",
      "-18\n",
      "-]\n",
      "-,\n",
      "-whereas\n",
      "-MT2\n",
      "-receptor\n",
      "-knockout\n",
      "-\n",
      "\n",
      "-mice\n",
      "-showed\n",
      "-decreased\n",
      "-NREMS\n",
      "-duration\n",
      "-[\n",
      "-18\n",
      "-]\n",
      "-.\n",
      "-Taken\n",
      "-\n",
      "\n",
      "-together\n",
      "-,\n",
      "-these\n",
      "-knockout\n",
      "-studies\n",
      "-seem\n",
      "-to\n",
      "-suggest\n",
      "-that\n",
      "-\n",
      "\n",
      "-MT1\n",
      "-and\n",
      "-MT2\n",
      "-receptors\n",
      "-modulate\n",
      "-NREMS\n",
      "-in\n",
      "-an\n",
      "-oppo-\n",
      "-\n",
      "\n",
      "-site\n",
      "-manner\n",
      "-[\n",
      "-16\n",
      "-]\n",
      "-.\n",
      "-By\n",
      "-activating\n",
      "-MT1\n",
      "-and\n",
      "-MT2\n",
      "-receptors\n",
      "-,\n",
      "-\n",
      "\n",
      "-melatonin\n",
      "-and\n",
      "-non\n",
      "--\n",
      "-selective\n",
      "-MT1\n",
      "-/\n",
      "-MT2\n",
      "-receptor\n",
      "-ago-\n",
      "-\n",
      "\n",
      "-nists\n",
      "-have\n",
      "-shown\n",
      "-to\n",
      "-improve\n",
      "-sleep\n",
      "-quality\n",
      "-,\n",
      "-increase\n",
      "-total\n",
      "-\n",
      "\n",
      "-sleep\n",
      "-time\n",
      "-,\n",
      "-improve\n",
      "-sleep\n",
      "-efficiency\n",
      "-and\n",
      "-decrease\n",
      "-sleep\n",
      "-\n",
      "\n",
      "-onset\n",
      "-latency\n",
      "-in\n",
      "-insomnia\n",
      "-patients\n",
      "-.\n",
      "-\n",
      "\n",
      "-Effect\n",
      "-of\n",
      "-melatonin\n",
      "-on\n",
      "-reducing\n",
      "-the\n",
      "-\n",
      "\n",
      "-complications\n",
      "-caused\n",
      "-by\n",
      "-SBDs\n",
      "-\n",
      "\n",
      "-SBDs\n",
      "-are\n",
      "-characterized\n",
      "-by\n",
      "-abnormalities\n",
      "-in\n",
      "-respira-\n",
      "-\n",
      "\n",
      "-tion\n",
      "-during\n",
      "-sleep\n",
      "-.\n",
      "-These\n",
      "-disorders\n",
      "-are\n",
      "-subcategorized\n",
      "-\n",
      "\n",
      "-into\n",
      "-obstructive\n",
      "-sleep\n",
      "-apnoea\n",
      "-(\n",
      "-OSA\n",
      "-)\n",
      "-disorders\n",
      "-,\n",
      "-central\n",
      "-\n",
      "\n",
      "-sleep\n",
      "-apnea\n",
      "-disorders\n",
      "-,\n",
      "-sleep\n",
      "--\n",
      "-related\n",
      "-hypoventilation\n",
      "-\n",
      "\n",
      "-disorders\n",
      "-and\n",
      "-sleep\n",
      "--\n",
      "-related\n",
      "-hypoxemia\n",
      "-disorders\n",
      "-[\n",
      "-9\n",
      "-]\n",
      "-.\n",
      "-\n",
      "\n",
      "-It\n",
      "-is\n",
      "-well\n",
      "-documented\n",
      "-that\n",
      "-SBDs\n",
      "-are\n",
      "-a\n",
      "-risk\n",
      "-factor\n",
      "-for\n",
      "-\n",
      "\n",
      "-cognitive\n",
      "-impairment\n",
      "-[\n",
      "-19\n",
      "-]\n",
      "-,\n",
      "-type\n",
      "-2\n",
      "-diabetes\n",
      "-[\n",
      "-20\n",
      "-]\n",
      "-,\n",
      "-early\n",
      "-\n",
      "\n",
      "-renal\n",
      "-damage\n",
      "-[\n",
      "-21\n",
      "-]\n",
      "-,\n",
      "-heart\n",
      "-failure\n",
      "-[\n",
      "-22\n",
      "-]\n",
      "-,\n",
      "-atrial\n",
      "-fibrillation\n",
      "-\n",
      "\n",
      "-[\n",
      "-23\n",
      "-]\n",
      "-,\n",
      "-coronary\n",
      "-disease\n",
      "-[\n",
      "-24\n",
      "-]\n",
      "-,\n",
      "-as\n",
      "-well\n",
      "-as\n",
      "-ischemic\n",
      "-stroke\n",
      "-\n",
      "\n",
      "-[\n",
      "-25\n",
      "-]\n",
      "-.\n",
      "-The\n",
      "-most\n",
      "-common\n",
      "-treatments\n",
      "-for\n",
      "-SBDs\n",
      "-are\n",
      "-con-\n",
      "-\n",
      "\n",
      "-tinuous\n",
      "- \n",
      "-positive\n",
      "- \n",
      "-airway\n",
      "-pressure\n",
      "- \n",
      "-(\n",
      "-CPAP\n",
      "-)\n",
      "-,\n",
      "-surgery\n",
      "-,\n",
      "-oral\n",
      "-\n",
      "\n",
      "-appliances\n",
      "-,\n",
      "-postural\n",
      "-therapy\n",
      "-and\n",
      "-weight\n",
      "-loss\n",
      "-.\n",
      "-However\n",
      "-,\n",
      "-\n",
      "\n",
      "-there\n",
      "-are\n",
      "-significant\n",
      "-disadvantages\n",
      "-related\n",
      "-to\n",
      "-the\n",
      "-above\n",
      "-\n",
      "\n",
      "-treatments\n",
      "-,\n",
      "-including\n",
      "-postoperative\n",
      "-recurrence\n",
      "-,\n",
      "-dental\n",
      "-\n",
      "\n",
      "-injury\n",
      "-in\n",
      "-the\n",
      "-case\n",
      "-of\n",
      "-oral\n",
      "-appliance\n",
      "-,\n",
      "-poor\n",
      "- \n",
      "-tolerance\n",
      "-to\n",
      "-\n",
      "\n",
      "-CPAP\n",
      "-,\n",
      "-poor\n",
      "-sleep\n",
      "-quality\n",
      "-secondary\n",
      "-to\n",
      "-postural\n",
      "-therapy\n",
      "-,\n",
      "-\n",
      "\n",
      "-and\n",
      "-difficulty\n",
      "-with\n",
      "-weight\n",
      "-loss\n",
      "-.\n",
      "-Considering\n",
      "-these\n",
      "-com-\n",
      "-\n",
      "\n",
      "-plications\n",
      "-and\n",
      "-disadvantages\n",
      "-,\n",
      "-new\n",
      "- \n",
      "-therapies\n",
      "- \n",
      "-for\n",
      "-SBDs\n",
      "-\n",
      "\n",
      "-are\n",
      "-urgently\n",
      "-needed\n",
      "-.\n",
      "-\n",
      "\n",
      "-Melatonin\n",
      "-has\n",
      "-been\n",
      "-shown\n",
      "-to\n",
      "-ameliorate\n",
      "-the\n",
      "-compli-\n",
      "-\n",
      "\n",
      "-cations\n",
      "-caused\n",
      "-by\n",
      "-SBDs\n",
      "-in\n",
      "-both\n",
      "-animal\n",
      "-models\n",
      "-,\n",
      "-as\n",
      "-well\n",
      "-\n",
      "\n",
      "-as\n",
      "-human\n",
      "-clinical\n",
      "-trials\n",
      "-.\n",
      "-Melatonin\n",
      "-prevents\n",
      "-the\n",
      "-well-­\n",
      "-\n",
      "\n",
      "-recognized\n",
      "-increase\n",
      "-in\n",
      "-glucose\n",
      "-levels\n",
      "-that\n",
      "-usually\n",
      "-follows\n",
      "-\n",
      "\n",
      "-exposure\n",
      "-to\n",
      "-intermittent\n",
      "-hypoxia\n",
      "-in\n",
      "-animal\n",
      "-models\n",
      "-of\n",
      "-\n",
      "\n",
      "-sleep\n",
      "-apnea\n",
      "-[\n",
      "-26\n",
      "-]\n",
      "-.\n",
      "-By\n",
      "-modulating\n",
      "-autophagy\n",
      "-through\n",
      "-the\n",
      "-\n",
      "\n",
      "-5′\n",
      "-adenosine\n",
      "-monophosphate\n",
      "--\n",
      "-activated\n",
      "-protein\n",
      "-kinase\n",
      "-\n",
      "\n",
      "-pathway\n",
      "-,\n",
      "-melatonin\n",
      "-protects\n",
      "-against\n",
      "-chronic\n",
      "-inter-\n",
      "-\n",
      "\n",
      "-mittent\n",
      "-hypoxia\n",
      "--\n",
      "-induced\n",
      "-cardiac\n",
      "-hypertrophy\n",
      "-in\n",
      "-rats\n",
      "-\n",
      "\n",
      "-[\n",
      "-27\n",
      "-]\n",
      "-.\n",
      "-Additionally\n",
      "-,\n",
      "-melatonin\n",
      "-inhibits\n",
      "-the\n",
      "-expression\n",
      "-of\n",
      "-\n",
      "\n",
      "-inflammatory\n",
      "-cytokines\n",
      "-(\n",
      "-Tumor\n",
      "-necrosis\n",
      "-factor\n",
      "-alpha\n",
      "-,\n",
      "-\n",
      "\n",
      "-Interleukin-6\n",
      "-,\n",
      "-and\n",
      "-Cyclooxygenase-2\n",
      "-)\n",
      "-and\n",
      "-fibrotic\n",
      "-mark-\n",
      "-\n",
      "\n",
      "-ers\n",
      "-(\n",
      "-PC1\n",
      "-and\n",
      "-TGF\n",
      "--\n",
      "-beta\n",
      "-)\n",
      "-.\n",
      "-Moreover\n",
      "-,\n",
      "-melatonin\n",
      "-treatment\n",
      "-\n",
      "\n",
      "-mitigates\n",
      "-Ca(2\n",
      "-+\n",
      "-)\n",
      "-overloading\n",
      "-,\n",
      "-decreased\n",
      "-Ca(2\n",
      "-+\n",
      "-)\n",
      "-content\n",
      "-\n",
      "\n",
      "-and\n",
      "-lower\n",
      "-expression\n",
      "-and\n",
      "-activity\n",
      "-of\n",
      "-Ca(2\n",
      "-+\n",
      "-)\n",
      "-,\n",
      "-leading\n",
      "-to\n",
      "-\n",
      "\n",
      "-decreased\n",
      "-cardiac\n",
      "-contractility\n",
      "-.\n",
      "-These\n",
      "-aforementioned\n",
      "-\n",
      "\n",
      "-mechanisms\n",
      "-contribute\n",
      "-to\n",
      "-cardiac\n",
      "-inflammation\n",
      "-,\n",
      "-vascu-\n",
      "-\n",
      "\n",
      "-lar\n",
      "-endothelium\n",
      "-dysfunction\n",
      "-and\n",
      "-ultimately\n",
      "-secondary\n",
      "-\n",
      "\n",
      "-hypertension\n",
      "-,\n",
      "-which\n",
      "-are\n",
      "-interceded\n",
      "-by\n",
      "-melatonin\n",
      "-.\n",
      "-\n",
      "\n",
      "-Melatonin\n",
      "-prevents\n",
      "-the\n",
      "-development\n",
      "-of\n",
      "-cardiovascu-\n",
      "-\n",
      "\n",
      "-lar\n",
      "-diseases\n",
      "-secondary\n",
      "-to\n",
      "-SBDs\n",
      "-through\n",
      "-several\n",
      "-mecha-\n",
      "-\n",
      "\n",
      "-nisms\n",
      "-.\n",
      "-Prophylactic\n",
      "-melatonin\n",
      "-in\n",
      "-OSA\n",
      "-patients\n",
      "-has\n",
      "-been\n",
      "-\n",
      "\n",
      "-shown\n",
      "-to\n",
      "-protect\n",
      "-against\n",
      "-chronic\n",
      "-intermittent\n",
      "-hypox-\n",
      "-\n",
      "\n",
      "-ia\n",
      "--\n",
      "-induced\n",
      "-myocardial\n",
      "-inflammation\n",
      "-and\n",
      "-fibrosis\n",
      "-[\n",
      "-28\n",
      "-]\n",
      "-by\n",
      "-\n",
      "\n",
      "-activating\n",
      "-MT1\n",
      "-and\n",
      "-MT2\n",
      "-receptors\n",
      "-downstreams\n",
      "-[\n",
      "-29\n",
      "-]\n",
      "-.\n",
      "-\n",
      "\n",
      "-Melatonin\n",
      "-and\n",
      "-melatonin\n",
      "--\n",
      "-mimicking\n",
      "-agents\n",
      "-inhibit\n",
      "-B2\n",
      "-\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for token in doc:\n",
    "    print(\"-\" + token.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "35f131c8",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
